A Randomized, Placebo Controlled Study to Evaluate the Safety and Potential Efficacy of MS-20 in Combination with Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Clinical trial NCT04909034 · COMPLETED
Trial details
- NCT number
- NCT04909034
- Sponsor
- Microbio Co Ltd
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-20
- Primary completion
- 2024-10-23
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.